All lobbying filings

DLA PIPER LLP (US)

DLA PIPER LLP (US) filed a Q4 report for XEROX HOLDINGS CORPORATION on January 16, 2026, reporting $60,000 in lobbying income.

Lobbying for XEROX HOLDINGS CORPORATION · Printing and imaging product manufacturer.

All filings by DLA PIPER LLP (US) · Everything XEROX HOLDINGS CORPORATION has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Kentucky

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Ensuring full patient access to drug label and package insert information. H.R. 5133, Patients Right to Know Their Medication Act of 2025.

Bills named in this filing 1

H.R. 5133
Patients’ Right to Know Their Medication Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.